Safe treatment of a patient with CML using dasatinib after prior retinal oedema due to imatinib

Leuk Res. 2008 Nov;32(11):1789-90. doi: 10.1016/j.leukres.2008.03.027. Epub 2008 May 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Benzamides
  • Dasatinib
  • Edema / chemically induced*
  • Edema / drug therapy
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Piperazines / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use*
  • Retinal Diseases / chemically induced*
  • Retinal Diseases / drug therapy
  • Thiazoles / therapeutic use*

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Dasatinib